From the Left
AllSides Media Bias Rating: Lean Left
The Food and Drug Administration on Thursday approved Journavx, a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years.
Vertex Pharmaceuticals, which makes the drug, has billed it as an effective alternative to opioids that isn’t addictive. Journavx works by intercepting pain signals before they reach the spinal cord, rather than acting directly on the brain. Vertex said the wholesale cost would be $15.50 per 50 milligram pill, or about $31 for a recommended starting dose.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Headline Roundup
US Loses Measles Elimination Status After 26 Years
November 17th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
Affordable Care Act
Recommended Reading
Do Phones Belong in Class?: Understanding the Phone-Free Schools Debate
The Alliance for Civic Engagement
November 20th, 2026